{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:01:28Z","timestamp":1790798488621,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejmech.2022.114260","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:23:06Z","timestamp":1647379386000},"page":"114260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Optimization of NAMPT activators to achieve in\u00a0vivo neuroprotective efficacy"],"prefix":"10.1016","volume":"236","author":[{"given":"Leibo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-7807","authenticated-orcid":false,"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-6214","authenticated-orcid":false,"given":"Weinan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haigen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-9446","authenticated-orcid":false,"given":"Gelin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-0608","authenticated-orcid":false,"given":"Yefeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114260_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1098\/rspb.1906.0029","article-title":"The alcoholic ferment of yeast-juice","volume":"77","author":"Harden","year":"1906","journal-title":"Proc. Roy. Soc. Lond. B"},{"key":"10.1016\/j.ejmech.2022.114260_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2022.114260_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-291X(63)90024-X","article-title":"Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme","volume":"11","author":"Chambon","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114260_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/bbrc.1999.0897","article-title":"Characterization of five human cDNAs with homology to the yeast SIR2 Gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-Ribosyltransferase activity","volume":"260","author":"Frye","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114260_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114260_bib6","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1073\/pnas.110148297","article-title":"The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases","volume":"97","author":"Landry","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2022.114260_bib7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/nar\/gky1202","article-title":"Human DNA ligase IV is able to use NAD+ as an alternative adenylation donor for DNA ends ligation","volume":"47","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejmech.2022.114260_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature18622","article-title":"The mechanism of RNA 5\u2032 capping with NAD+, NADH and desphospho-CoA","volume":"535","author":"Bird","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114260_bib9","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1038\/s41598-017-06254-4","article-title":"Quinolinate phosphoribosyltransferase is an antiviral host factor Against hepatitis C virus infection","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114260_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.virol.2019.08.024","article-title":"PARP-1 mediated cell death is directly activated by ZIKV infection","volume":"537","author":"Xu","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2022.114260_bib11","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1161\/CIRCULATIONAHA.117.032626","article-title":"Raising NAD in heart failure: time to translate?","volume":"137","author":"Walker","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2022.114260_bib12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/jcb.22704","article-title":"Nicotinamide phosphoribosyltransferase\/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation","volume":"110","author":"Zhang","year":"2010","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2022.114260_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114260_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00125-019-4831-3","article-title":"NAD+ metabolism as a target for metabolic health: have we found the silver bullet?","volume":"62","author":"Connell","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2022.114260_bib15","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.15252\/embj.201797135","article-title":"Modulating NAD+ metabolism, from bench to bedside","volume":"36","author":"Katsyuba","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.ejmech.2022.114260_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1089\/ars.2017.7445","article-title":"NAD+ deficiency is a common central pathological factor of a number of diseases and aging: mechanisms and therapeutic implications","volume":"30","author":"Zhang","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2022.114260_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2022.114260_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in\u00a0vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2022.114260_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cmet.2018.02.001","article-title":"Nicotinamide improves aspects of healthspan, but not lifespan, in mice","volume":"27","author":"Mitchell","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2022.114260_bib20","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114260_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","article-title":"Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes","volume":"105","author":"Hsu","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2022.114260_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.07.040","article-title":"P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114260_bib23","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41467-019-11078-z","article-title":"Boosting NAD+ with a small molecule that activates NAMPT","volume":"10","author":"Gardell","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114260_bib24","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1523\/JNEUROSCI.2320-06.2006","article-title":"Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy","volume":"26","author":"Sasaki","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114260_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114260_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2022.114260_bib27","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db12-1139","article-title":"Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome","volume":"62","author":"Escande","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2022.114260_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2022.114260_bib29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Beny\u00f3","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114260_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s001250051536","article-title":"Safety of high-dose nicotinamide: a review","volume":"43","author":"Knip","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2022.114260_bib31","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.chembiol.2016.12.003","article-title":"PARP inhibitors: staying on target?","volume":"23","author":"Doig","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114260_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nsmb1114","article-title":"Structure of Nampt\/PBEF\/visfatin, a mammalian NAD+ biosynthetic enzyme","volume":"13","author":"Wang","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114260_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-nutr-071811-150746","article-title":"Visfatin\/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology","volume":"32","author":"Dahl","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejmech.2022.114260_bib34","first-page":"39","article-title":"Discovery of a proneurogenic","volume":"142","author":"Pieper","year":"2010","journal-title":"Neuroprotective Chemical, Cell"},{"key":"10.1016\/j.ejmech.2022.114260_bib35","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/jm401919s","article-title":"Discovery of a neuroprotective chemical, (S)- N -(3-(3,6-Dibromo-9 H -carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(\u2212)-P7C3-S243], with improved druglike properties","volume":"57","author":"Naidoo","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib36","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1039\/C3CS60448A","article-title":"P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases","volume":"43","author":"Pieper","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2022.114260_bib37","doi-asserted-by":"crossref","first-page":"128007","DOI":"10.1016\/j.bmcl.2021.128007","article-title":"Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators","volume":"41","author":"Pinkerton","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114260_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and applications of halogen bonding in medicinal chemistry and chemical Biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-022-00651-9","article-title":"Discovery of Small-Molecule Activators of Nicotinamide Phosphoribosyltransferase (NAMPT) and Their Preclinical Neuroprotective Activity","author":"Yao","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.ejmech.2022.114260_bib40","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejmech.2022.114260_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41398-018-0244-1","article-title":"Neuroprotective efficacy of P7C3 compounds in primate hippocampus","volume":"8","author":"Bauman","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmech.2022.114260_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.09.024","article-title":"Neurotherapeutic capacity of P7C3 agents for the treatment of traumatic brain injury","volume":"145","author":"Blaya","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114260_bib43","first-page":"488","article-title":"(\u2212)-P7C3-S243 protects a rat model of Alzheimer's disease from neuropsychiatric deficits and neurodegeneration without altering amyloid deposition or reactive Glia","volume":"84","author":"Voorhees","year":"2018","journal-title":"Mech. Neurodegener. Neuroprotection."},{"key":"10.1016\/j.ejmech.2022.114260_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29626","article-title":"Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy","volume":"6","author":"LoCoco","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2022.114260_bib45","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/jm981106w","article-title":"Characterization of the binding site of the histamine H 3 receptor. 2. Synthesis, in\u00a0vitro pharmacology, and QSAR of a series of monosubstituted benzyl analogues of thioperamide","volume":"43","author":"Windhorst","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1099-0690(200101)2001:1<137::AID-EJOC137>3.0.CO;2-#","article-title":"Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase","volume":"1","author":"Arenz","year":"2001","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib47","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1002\/anie.201406393","article-title":"Photocatalytic synthesis of dihydrobenzofurans by oxidative [3+2] cycloaddition of phenols","volume":"53","author":"Blum","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.114260_bib48","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ejic.201201549","article-title":"Synthesis of differently substituted tacn-based ligands: towards the control of solubility and electronic and steric properties of uranium coordination complexes: tacn-based uranium coordination complexes","volume":"2013","author":"Nizovtsev","year":"2013","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib49","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/jacs.6b03113","article-title":"Development of highly active and regioselective catalysts for the copolymerization of epoxides with cyclic anhydrides: an unanticipated effect of electronic variation","volume":"138","author":"DiCiccio","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114260_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nchem.1284","article-title":"Self-assembly of the oxy-tyrosinase core and the fundamental components of phenolic hydroxylation","volume":"4","author":"Citek","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib51","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1021\/acscatal.9b03426","article-title":"NHC ligand-enabled, palladium-catalyzed non-directed C(sp3)\u2013H carbonylation to access indanone cores","volume":"9","author":"Cai","year":"2019","journal-title":"ACS Catal"},{"key":"10.1016\/j.ejmech.2022.114260_bib52","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/jo001115o","article-title":"Temporary inactivation of plasma amine oxidase by alkylhydrazines. A combined enzyme\/model study implicates cofactor reduction\/Reoxidation but cofactor deoxygenation and subsequent reoxygenation in the case of hydrazine itself","volume":"66","author":"Lee","year":"2001","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114260_bib53","series-title":"Phenoxymethyl Derivatives, WO2017037146","author":"Jerome","year":"2017"},{"key":"10.1016\/j.ejmech.2022.114260_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/anie.200804446","article-title":"Copper-catalyzed asymmetric michael addition of magnesium, zinc, and aluminum organometallic reagents: efficient synthesis of chiral molecules","volume":"48","author":"Thaler","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.114260_bib55","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1055\/s-0037-1609581","article-title":"Toward a catalytic atroposelective synthesis of diaryl ethers through C(sp2)\u2013H alkylation with nitroalkanes","volume":"29","author":"Dinh","year":"2018","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2022.114260_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ab.2010.12.035","article-title":"A\u00a0fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase","volume":"412","author":"Zhang","year":"2011","journal-title":"Anal. Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:39:23Z","timestamp":1759329563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":56,"alternative-id":["S0223523422001623"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114260","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of NAMPT activators to achieve in\u00a0vivo neuroprotective efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114260"}}